Cancer recurrence and survival among patients who underwent neoadjuvant treatment and surgery for esophageal cancer: A single-institution 10-year experience
View abstract on PubMed
Summary
This summary is machine-generated.Older age and poor cellular differentiation are key factors impacting survival in locally advanced esophageal cancer. Advanced N stage and cellular differentiation also increase recurrence risk, guiding personalized treatment strategies.
Area Of Science
- Oncology
- Surgical Oncology
- Gastroenterology
Background
- Standard treatment for locally advanced esophageal cancer involves neoadjuvant therapy followed by surgical resection.
- Minimally invasive esophagectomy is increasingly utilized for esophageal cancer treatment.
Purpose Of The Study
- To identify perioperative factors associated with recurrence and survival in patients with locally advanced esophageal cancer.
- To explore risk and protective factors influencing recurrence-free and overall survival after neoadjuvant therapy and minimally invasive esophagectomy.
Main Methods
- Retrospective analysis of prospectively collected data from minimally invasive Ivor Lewis esophagectomy cases (September 2013 - September 2023).
- Application of univariable and multivariable Cox proportional hazard regression models.
- Inclusion of 222 patients who received neoadjuvant chemoradiation followed by surgery.
Main Results
- On multivariable analysis, advanced N stage and worsening cellular differentiation were significant risk factors for recurrence.
- Older age and poorer cellular differentiation were independently associated with reduced overall survival.
- N stage and age emerged as strong independent risk factors for both recurrence and survival.
Conclusions
- Older age and cellular differentiation are significant independent risk factors for overall survival in locally advanced esophageal cancer.
- N stage and age are critical independent risk factors affecting both recurrence and survival.
- Findings can inform treatment decisions and shared decision-making to optimize patient outcomes.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Cervical Esophageal Perforations: Symptoms may include neck pain, difficulty swallowing, painful...

